SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
256Eur J Pharmacol 2002 Jul 19;448(2-3):231-238 PPARgamma ligands inhibit nitrotyscaram(o)uche-8/9/2002
255cool!..... DNA partners anti-CD11a with Serono for "Europe plus"...scaram(o)uche-8/8/2002
254[ DNA/XOMA/anti-CD11a ] The marketing strategy, big-time efficacy, is actually scaram(o)uche-8/2/2002
253Biologic Therapy for Psoriasis: The New Therapeutic Frontier Singri P, West DP, Arthur Radley-8/1/2002
252>>Celltech deserves better news<< Couldn't agree more. Though keokalani'nui-7/30/2002
251(Bad) luck of the draw, then?? Celltech <i>deserves</i> better newsscaram(o)uche-7/30/2002
250Remicade label refers to 2 trials involving 202 Crohns pts. fda.govkeokalani'nui-7/30/2002
249anybody remember how large the Centocor trial was? Tuesday July 30, 7:31 am Easscaram(o)uche-7/30/2002
248Someday---we will see real breakthroughs for RA and Psoriasis. It is still the hjayhawk969-7/19/2002
247[ Deltagen/new GPCR target ] Sounds sort of "ho hum, another?" until scaram(o)uche-7/18/2002
246[ PDLI/anti-CD3/ulcerative colitis ] <i>(these guys must have an incredibscaram(o)uche-7/9/2002
245[ more VLA-4, Wyeth/Elan ] ditto, not the result of an exhaustive search, but jscaram(o)uche-7/7/2002
244[ more alpha4beta7 ] haven't done an exhaustive search, just wandered acrosscaram(o)uche-7/7/2002
243[ Merck and Genentech, related stuff ] J Pharmacol Exp Ther 2002 Jul;302(1):153scaram(o)uche-7/1/2002
242[ Biogen/VLA-4 antagonists ] J Med Chem 2002 Jul 4;45(14):2988-93 Identificatscaram(o)uche-7/1/2002
241From the June 21, 2002 print edition aknahow-6/27/2002
240[ D2E7/RA ] First Phase III Data for Abbott Laboratories' D2E7 (Adalimumab)scaram(o)uche-6/14/2002
239[ "Complete Response" Letter/Amevive ] Thursday June 13, 4:02 pm Eastscaram(o)uche-6/13/2002
238<edit> IDEC-131 the full text - didn't notice already posted... SAN Dnigel bates-6/10/2002
237[ IDPH/anti-CD40L ] Message 17583280scaram(o)uche-6/10/2002
236The model is indomethacin, its more potent than aspirin, and the IV form createsCacaito-6/7/2002
235Nigel, I read something a few days ago about sod. bicarb(can't remember wherArthur Radley-6/5/2002
234Any reason you can't just take a daily dose of sodium bicarbonate as well ?nigel bates-6/5/2002
233A very good read on NSAID's, ulcers, the cox enzymes. Gives a good grasp ofrusset-6/5/2002
232Many Heart Patients Still Don't Take Aspirin Mon Jun 3, 5:35 PM ET NEW YOArthur Radley-6/5/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News